|
|
| G
|
Cdipt
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
multiple interactions
|
ISO
|
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate
|
CTD |
PMID:2579070 |
|
NCBI chr 1:191,013,632...191,017,943
Ensembl chr 1:191,013,463...191,017,971
|
|
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
EXP
|
Cytidine Triphosphate affects the folding of [Tetrachlorodibenzodioxin binds to AHR protein]
|
CTD |
PMID:1848756 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
App
|
amyloid beta precursor protein
|
increases secretion
|
ISO
|
Cytidine Triphosphate results in increased secretion of APP protein modified form
|
CTD |
PMID:22906069 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
P2rx1
|
purinergic receptor P2X 1
|
affects binding
|
EXP
|
CTP binds to P2rx1 protein
|
RGD |
PMID:12237343 |
RGD:727431 |
NCBI chr10:58,117,107...58,132,167
Ensembl chr10:58,117,088...58,132,164
|
|
| G
|
P2rx5
|
purinergic receptor P2X 5
|
affects transport
|
EXP
|
CTP affects transport ion flux of P2rx5 receptor
|
RGD |
PMID:12237343 |
RGD:727431 |
NCBI chr10:58,276,329...58,291,108
Ensembl chr10:58,276,257...58,287,935
|
|
|
|
| G
|
Cdipt
|
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
|
multiple interactions
|
ISO
|
[delta-hexachlorocyclohexane results in decreased activity of CDIPT protein] which results in decreased abundance of Cytidine Monophosphate; [Inositol promotes the reaction [CDIPT protein results in increased metabolism of Cytidine Diphosphate Diglycerides]] which results in increased abundance of Cytidine Monophosphate
|
CTD |
PMID:2579070 |
|
NCBI chr 1:191,013,632...191,017,943
Ensembl chr 1:191,013,463...191,017,971
|
|
|
|
| G
|
Cxcl2
|
C-X-C motif chemokine ligand 2
|
multiple interactions
|
ISO
|
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]
|
CTD |
PMID:18523137 |
|
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,465,242...17,467,255
|
|
| G
|
Cysltr1
|
cysteinyl leukotriene receptor 1
|
multiple interactions
|
ISO
|
[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium; [Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein; montelukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; montelukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]; Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein; zafirlukast inhibits the reaction [[Uridine Diphosphate binds to and results in increased activity of CYSLTR1 protein] which results in increased abundance of Calcium]; zafirlukast inhibits the reaction [[Uridine Diphosphate metabolite results in increased activity of CYSLTR1 protein] which results in increased expression of CXCL8 protein]
|
CTD |
PMID:20083671 |
|
NCBI chr X:75,734,281...75,762,873
Ensembl chr X:75,734,270...75,763,050
|
|
| G
|
Gpr17
|
G protein-coupled receptor 17
|
multiple interactions
|
ISO
|
cangrelor inhibits the reaction [Uridine Diphosphate results in increased activity of GPR17 protein]
|
CTD |
PMID:18974869 |
|
NCBI chr18:23,850,460...23,857,381
Ensembl chr18:23,850,107...23,857,702
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
Uridine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
|
CTD |
PMID:32941855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Idh2
|
isocitrate dehydrogenase (NADP(+)) 2
|
increases abundance multiple interactions
|
ISO
|
IDH2 protein mutant form results in increased abundance of Uridine Diphosphate Triazines inhibits the reaction [IDH2 protein mutant form results in increased abundance of Uridine Diphosphate]
|
CTD |
PMID:27469509 |
|
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:143,439,323...143,467,248
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO
|
MRS 2211 inhibits the reaction [Uridine Diphosphate results in increased expression of IL6 protein]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]
|
CTD |
PMID:18523137 PMID:24849676 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
increases phosphorylation multiple interactions
|
ISO
|
Uridine Diphosphate results in increased phosphorylation of MAPK1 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein]
|
CTD |
PMID:15034929 PMID:18523137 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
increases phosphorylation multiple interactions
|
ISO
|
Uridine Diphosphate results in increased phosphorylation of MAPK3 protein P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein]
|
CTD |
PMID:15034929 PMID:18523137 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
P2ry6
|
pyrimidinergic receptor P2Y6
|
multiple interactions affects response to substance
|
ISO
|
P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of CXCL2 protein]]; P2RY6 gene affects the reaction [Uridine Diphosphate promotes the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK1 protein]; P2RY6 gene mutant form inhibits the reaction [Uridine Diphosphate results in increased phosphorylation of MAPK3 protein] P2RY6 gene affects the susceptibility to Uridine Diphosphate
|
CTD |
PMID:18523137 |
|
NCBI chr 1:164,707,188...164,742,689
Ensembl chr 1:164,706,116...164,743,588
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
Uridine Diphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
|
CTD |
PMID:32941855 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
|
|
| G
|
Bsg
|
basigin
|
decreases expression
|
ISO
|
Uridine Monophosphate results in decreased expression of BSG protein
|
CTD |
PMID:36574092 |
|
NCBI chr 7:10,643,788...10,651,005
Ensembl chr 7:10,643,789...10,651,005
|
|
|
|
| G
|
Ahr
|
aryl hydrocarbon receptor
|
multiple interactions
|
EXP
|
Uridine Triphosphate affects the folding of [Tetrachlorodibenzodioxin binds to AHR protein]
|
CTD |
PMID:1848756 |
|
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:57,961,423...57,998,901
|
|
| G
|
Calca
|
calcitonin-related polypeptide alpha
|
multiple interactions
|
EXP
|
Uridine Triphosphate promotes the reaction [Protons results in increased secretion of CALCA protein]
|
CTD |
PMID:12044622 |
|
NCBI chr 1:178,312,636...178,317,588
Ensembl chr 1:178,312,638...178,317,529
|
|
| G
|
Egfr
|
epidermal growth factor receptor
|
increases phosphorylation
|
EXP
|
Uridine Triphosphate results in increased phosphorylation of EGFR protein
|
CTD |
PMID:14676212 |
|
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:95,378,626...95,551,358
|
|
| G
|
Gnaq
|
G protein subunit alpha q
|
multiple interactions
|
EXP
|
Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]
|
CTD |
PMID:14676212 |
|
NCBI chr 1:222,852,453...223,098,754
Ensembl chr 1:222,852,097...223,126,742
|
|
| G
|
H2ax
|
H2A.X variant histone
|
multiple interactions
|
ISO
|
Uridine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of H2AX protein modified form]
|
CTD |
PMID:32941855 |
|
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:53,568,281...53,573,079
|
|
| G
|
Hcar2
|
hydroxycarboxylic acid receptor 2
|
multiple interactions
|
ISO
|
[Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]
|
CTD |
PMID:16674924 |
|
NCBI chr12:38,387,163...38,389,149
Ensembl chr12:38,387,230...38,389,391
|
|
| G
|
Il6
|
interleukin 6
|
multiple interactions increases expression
|
ISO
|
NF157 compound inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein]; Suramin inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein] MRS 2211 inhibits the reaction [Uridine Triphosphate results in increased expression of IL6 protein]
|
CTD |
PMID:24793913 PMID:24849676 |
|
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
|
|
| G
|
Mapk1
|
mitogen activated protein kinase 1
|
multiple interactions increases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids]; [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] which results in increased abundance of Arachidonic Acids; Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein RTKI cpd inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK1 protein] Uridine Triphosphate results in increased phosphorylation of MAPK1 protein
|
CTD |
PMID:14676212 PMID:15034929 PMID:16674924 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
|
|
| G
|
Mapk3
|
mitogen activated protein kinase 3
|
multiple interactions increases phosphorylation
|
ISO EXP
|
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [Nicotinic Acids results in increased activity of HCAR2 protein] promotes the reaction [[Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids]; [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] which results in increased abundance of Arachidonic Acids; Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein RTKI cpd inhibits the reaction [Uridine Triphosphate results in increased phosphorylation of and results in increased activity of MAPK3 protein] Uridine Triphosphate results in increased phosphorylation of MAPK3 protein
|
CTD |
PMID:14676212 PMID:15034929 PMID:16674924 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
|
|
| G
|
Myl2
|
myosin light chain 2
|
multiple interactions
|
EXP
|
Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]
|
CTD |
PMID:14676212 |
|
NCBI chr12:40,114,964...40,126,236
Ensembl chr12:40,114,958...40,129,149
|
|
| G
|
Myocd
|
myocardin
|
multiple interactions
|
EXP
|
Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of MYL2 protein]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein]
|
CTD |
PMID:14676212 |
|
NCBI chr10:50,332,356...50,426,819
Ensembl chr10:50,332,356...50,426,819
|
|
| G
|
Nppa
|
natriuretic peptide A
|
multiple interactions increases expression
|
EXP
|
Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]]; Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein]; Uridine Triphosphate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] Uridine Triphosphate results in increased expression of NPPA mRNA
|
CTD |
PMID:14676212 |
|
NCBI chr 5:163,712,184...163,713,493
Ensembl chr 5:163,712,184...163,713,493
|
|
| G
|
P2rx1
|
purinergic receptor P2X 1
|
affects binding
|
EXP
|
UTP binds to P2rx1 protein
|
RGD |
PMID:12237343 |
RGD:727431 |
NCBI chr10:58,117,107...58,132,167
Ensembl chr10:58,117,088...58,132,164
|
|
| G
|
P2ry2
|
purinergic receptor P2Y2
|
multiple interactions
|
EXP ISO
|
Uridine Triphosphate binds to and results in increased activity of P2RY2 protein Endocannabinoids inhibits the reaction [Uridine Triphosphate binds to and results in increased activity of P2RY2 protein]; Uridine Triphosphate binds to and results in increased activity of P2RY2 protein
|
CTD |
PMID:15654852 PMID:30102254 |
|
NCBI chr 1:164,764,119...164,779,578
Ensembl chr 1:164,759,213...164,781,852
|
|
| G
|
P2ry4
|
pyrimidinergic receptor P2Y4
|
multiple interactions
|
EXP
|
Uridine Triphosphate binds to and results in increased activity of P2RY4 protein
|
CTD |
PMID:15654852 |
|
NCBI chr X:69,722,604...69,757,726
Ensembl chr X:69,721,753...69,753,510
|
|
| G
|
Panx1
|
Pannexin 1
|
decreases activity
|
ISO
|
Uridine Triphosphate results in decreased activity of PANX1 protein
|
CTD |
PMID:19023039 |
|
NCBI chr 8:20,128,783...20,171,200
Ensembl chr 8:20,132,165...20,171,200
|
|
| G
|
Sftpb
|
surfactant protein B
|
increases secretion
|
ISO
|
Uridine Triphosphate results in increased secretion of SFTPB protein
|
CTD |
PMID:14565945 |
|
NCBI chr 4:105,917,495...105,926,631
Ensembl chr 4:105,917,578...105,927,646
|
|
| G
|
Sftpc
|
surfactant protein C
|
increases secretion
|
ISO
|
Uridine Triphosphate results in increased secretion of SFTPC protein
|
CTD |
PMID:14565945 |
|
NCBI chr15:52,006,274...52,009,324
Ensembl chr15:52,006,283...52,009,475
|
|
| G
|
Tp53bp1
|
tumor protein p53 binding protein 1
|
multiple interactions
|
ISO
|
Uridine Triphosphate inhibits the reaction [Cesium-137 results in increased expression of and affects the localization of TP53BP1 protein]
|
CTD |
PMID:32941855 |
|
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:128,620,322...128,696,747
|
|
| G
|
Trpc3
|
transient receptor potential cation channel, subfamily C, member 3
|
multiple interactions increases activity
|
ISO
|
ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate inhibits the reaction [Uridine Triphosphate results in increased activity of TRPC3 protein]
|
CTD |
PMID:19289841 |
|
NCBI chr 2:121,409,436...121,487,095
Ensembl chr 2:121,409,436...121,475,823
|
|
| G
|
Trpc5
|
transient receptor potential cation channel, subfamily C, member 5
|
increases activity
|
ISO
|
Uridine Triphosphate results in increased activity of TRPC5 protein
|
CTD |
PMID:19289841 |
|
NCBI chr X:112,742,828...113,027,638
Ensembl chr X:112,742,828...113,027,638
|
|
| G
|
Trpc6
|
transient receptor potential cation channel, subfamily C, member 6
|
increases activity
|
ISO
|
Uridine Triphosphate results in increased activity of TRPC6 protein
|
CTD |
PMID:19289841 |
|
NCBI chr 8:14,044,216...14,148,808
Ensembl chr 8:14,043,877...14,149,304
|
|
| G
|
Trpc7
|
transient receptor potential cation channel, subfamily C, member 7
|
increases activity
|
ISO
|
Uridine Triphosphate results in increased activity of TRPC7 protein
|
CTD |
PMID:19289841 |
|
NCBI chr17:7,707,954...7,839,064
Ensembl chr17:7,714,505...7,838,745
|
|